Pomegranate Juice for Type 2 Diabetes: A Sweet Solution?

Introduction

Pomegranate juice for type 2 diabetes has been gaining attention in recent years as a potential natural aid in managing this chronic condition. With its rich history and cultural significance, the pomegranate has long been revered as a "wonder fruit" in many parts of the world, particularly in the Middle East where it originated. Now, modern science is beginning to unravel the potential health benefits of this ruby-red fruit, especially for those living with type 2 diabetes.

Type 2 diabetes is a complex metabolic disorder characterised by high blood glucose levels and insulin resistance. As the prevalence of this condition continues to rise globally, there is an increasing focus on dietary interventions that may help manage blood sugar levels and mitigate associated complications. Pomegranate juice, with its unique nutritional profile and bioactive compounds, has emerged as a subject of interest in this context.

Rich in polyphenols, particularly punicalagins, anthocyanins, and ellagic acid, pomegranate juice boasts a powerful antioxidant capacity that surpasses that of many other fruits and beverages, including green tea and red wine (Aviram et al., 2000). These antioxidants, along with the fruit's vitamins, minerals, and fibre content (in whole fruit form), contribute to its potential health-promoting properties. However, it's important to note that while pomegranate juice shows promise, its effects on type 2 diabetes are still being studied, and more research is needed to fully understand its role in diabetes management.

Here is the main body of the article on pomegranate juice for type 2 diabetes:

Glycemic Impact of Pomegranate Juice

Glycemic Index and Load of Pomegranate

The glycemic index (GI) and glycemic load (GL) are important measures for individuals with type 2 diabetes when considering dietary choices. The GI ranks carbohydrate-containing foods based on how quickly they raise blood glucose levels, while the GL takes into account both the GI and the amount of carbohydrates in a serving.

Pomegranate has a low glycemic index of 35 and a moderate glycemic load of 18 (Foster-Powell et al., 2002). This relatively low GI and moderate GL suggest that pomegranate juice may not cause rapid spikes in blood glucose levels when consumed in moderation. Compared to other fruits and juices, pomegranate ranks favourably. For instance, orange juice has a higher GI of 50 and a GL of 12, while apple juice has a GI of 41 and a GL of 11 (Foster-Powell et al., 2002).

The low GI of pomegranate can be attributed to its unique sugar composition and the presence of polyphenols that may slow down sugar absorption. However, it's important to note that the GL of 18 is considered moderate, indicating that portion control is still crucial for individuals with diabetes.

Effects on Blood Glucose Levels

Research on the effects of pomegranate juice on blood glucose levels has yielded mixed results. Some studies have reported positive outcomes, while others have found no significant impact.

A study by Banihani et al. (2014) found that consumption of fresh pomegranate juice (1.5 mL per kg body weight) significantly decreased fasting blood glucose levels in type 2 diabetic patients after three hours. The researchers observed a 25% reduction in fasting blood glucose compared to baseline levels.

However, a more recent systematic review and meta-analysis by Sahebkar et al. (2017) concluded that pomegranate juice consumption did not have a significant effect on fasting blood glucose or glycated haemoglobin (HbA1c) levels in individuals with type 2 diabetes. The authors noted that the quality of evidence was low to moderate and called for more robust, long-term clinical trials.

Interestingly, some research has focused on the postprandial glycemic response when pomegranate juice is consumed with other foods. A study by Kerimi et al. (2017) found that pomegranate juice consumption reduced the postprandial glycemic response when consumed with bread, a high glycemic index food. This suggests that pomegranate juice may have a role in moderating blood glucose spikes after meals.

Potential Mechanisms of Glycemic Control

Several mechanisms have been proposed to explain how pomegranate juice might influence glycemic control:

1. Inhibition of digestive enzymes: Pomegranate polyphenols have been shown to inhibit α-amylase and α-glucosidase, enzymes involved in carbohydrate digestion. A study by Li et al. (2005) demonstrated that pomegranate flower extract inhibited these enzymes in vitro, potentially slowing down carbohydrate digestion and absorption.

2. Modulation of carbohydrate metabolism: Some research suggests that pomegranate compounds may influence glucose uptake and utilisation in cells. A study by Rozenberg et al. (2006) found that pomegranate juice increased glucose uptake in muscle cells and decreased glucose production in liver cells in diabetic mice.

3. Influence on glucose homeostasis: Pomegranate juice may affect hormones and signalling pathways involved in glucose regulation. For instance, Banihani et al. (2013) proposed that punicic acid, a fatty acid found in pomegranate seeds, might enhance insulin secretion and sensitivity.

While these mechanisms are promising, it's important to note that many of these studies were conducted in vitro or in animal models. More human clinical trials are needed to confirm these effects and their relevance to type 2 diabetes management.

Antioxidant Properties of Pomegranate Juice

Polyphenol Content and Antioxidant Capacity

Pomegranate juice is renowned for its high polyphenol content and potent antioxidant capacity. The main polyphenols in pomegranate include:

1. Punicalagins: These are the most abundant polyphenols in pomegranate and are responsible for much of its antioxidant activity.
2. Anthocyanins: These give pomegranate its rich red colour and contribute to its antioxidant properties.
3. Ellagic acid: This polyphenol is found in both free and bound forms in pomegranate.

A study by Gil et al. (2000) found that pomegranate juice had three times the antioxidant activity of red wine and green tea. The total polyphenol content of pomegranate juice was reported to be 2566 mg/L expressed as gallic acid equivalents.

The bioavailability and metabolism of pomegranate antioxidants are complex. While some compounds are absorbed intact, others are metabolised by gut bacteria into compounds like urolithins, which may have their own health benefits (Espín et al., 2013).

Reduction of Oxidative Stress in Diabetes

Oxidative stress plays a significant role in the pathogenesis of type 2 diabetes and its complications. The antioxidants in pomegranate juice may help combat this oxidative stress.

A study by Fenercioglu et al. (2010) investigated the effects of pomegranate juice on oxidative stress in type 2 diabetic patients. After 3 months of daily pomegranate juice consumption, participants showed significant decreases in serum malondialdehyde (a marker of oxidative stress) and increases in erythrocyte glutathione peroxidase activity (an antioxidant enzyme).

Another study by Sohrab et al. (2014) found that 8 weeks of pomegranate juice consumption (200 mL/day) in type 2 diabetic patients significantly increased serum total antioxidant capacity and reduced malondialdehyde levels compared to the control group.

Protection of Pancreatic Beta Cells

Pancreatic beta cells, which produce insulin, are particularly vulnerable to oxidative stress in diabetes. Some research suggests that pomegranate antioxidants may help protect these cells.

A study by Banihani et al. (2013) proposed that punicic acid from pomegranate seeds might protect beta cells from lipotoxicity and oxidative stress. The researchers suggested that this could help preserve insulin secretion capacity in diabetes.

In an animal study, Bagri et al. (2009) found that pomegranate extract administration to diabetic rats resulted in increased insulin levels and improved pancreatic beta cell function. While promising, these findings need to be confirmed in human studies.

Insulin Sensitivity and Pomegranate Juice

Effects on Insulin Levels and Sensitivity

Several studies have investigated the effects of pomegranate juice on insulin levels and sensitivity, with some promising results.

A study by Banihani et al. (2014) found that consumption of fresh pomegranate juice increased peripheral insulin levels in both healthy and diabetic subjects. The increase was more pronounced in diabetic individuals, suggesting a potential insulin-sensitising effect.

In a randomised controlled trial by Sohrab et al. (2014), type 2 diabetic patients who consumed 200 mL of pomegranate juice daily for 6 weeks showed significant decreases in fasting insulin levels and improvements in insulin sensitivity (as measured by the HOMA-IR index) compared to the control group.

Activation of PPAR-γ

One potential mechanism for pomegranate's effects on insulin sensitivity involves the activation of peroxisome proliferator-activated receptor gamma (PPAR-γ). PPAR-γ is a nuclear receptor that plays a crucial role in glucose metabolism and insulin sensitivity.

A study by Khoo et al. (2011) found that punicic acid from pomegranate seed oil activated PPAR-γ and PPAR-α in vitro. The researchers suggested that this activation could contribute to improved insulin sensitivity and lipid metabolism.

Another study by Hontecillas et al. (2009) demonstrated that punicic acid improved glucose tolerance and insulin sensitivity in mice, possibly through PPAR-γ-dependent mechanisms.

Influence on Resistin Levels

Resistin is an adipokine that has been associated with insulin resistance. Some research suggests that pomegranate compounds may influence resistin levels.

A study by Makino-Wakagi et al. (2012) found that ellagic acid from pomegranate suppressed resistin secretion from mouse adipocytes. The researchers proposed that this could be one mechanism by which pomegranate improves insulin sensitivity.

However, human studies on pomegranate's effects on resistin levels in type 2 diabetes are limited, and more research is needed to confirm these findings.

Anti-Inflammatory Properties of Pomegranate Juice

Chronic Inflammation in Type 2 Diabetes

Chronic low-grade inflammation is a hallmark of type 2 diabetes and contributes to insulin resistance and disease progression. Common inflammatory markers in diabetes include C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α).

Pomegranate's Anti-Inflammatory Mechanisms

Pomegranate juice and its compounds have demonstrated anti-inflammatory properties in several studies:

1. Inhibition of NF-κB activation: Nuclear factor kappa B (NF-κB) is a key regulator of inflammatory responses. A study by Rasheed et al. (2009) found that pomegranate extract inhibited NF-κB activation in human chondrocytes, suggesting a potential anti-inflammatory effect.

2. Effects on inflammatory cytokines: Research by Sohrab et al. (2014) showed that 8 weeks of pomegranate juice consumption (200 mL/day) in type 2 diabetic patients significantly reduced serum high-sensitivity CRP levels compared to the control group.

3. Modulation of macrophage activity: Macrophages play a crucial role in inflammation. A study by Lee et al. (2010) demonstrated that pomegranate polyphenols suppressed inflammatory cytokine production in macrophages, potentially contributing to an anti-inflammatory effect.

Potential Benefits for Diabetes-Related Complications

The anti-inflammatory properties of pomegranate juice may have implications for diabetes-related complications:

1. Cardiovascular health: Inflammation is a key factor in cardiovascular disease, a common complication of diabetes. A study by Aviram et al. (2004) found that pomegranate juice consumption reduced carotid intima-media thickness, a marker of atherosclerosis, in patients with carotid artery stenosis.

2. Neuropathy: Inflammation contributes to diabetic neuropathy. While direct studies on pomegranate and diabetic neuropathy are limited, the anti-inflammatory properties of pomegranate may potentially benefit this condition.

3. Nephropathy: Kidney inflammation is involved in diabetic nephropathy. A study by Tugcu et al. (2008) in diabetic rats found that pomegranate extract reduced oxidative stress and inflammation in the kidneys, suggesting a potential protective effect.

While these findings are promising, more human clinical trials are needed to fully establish the anti-inflammatory benefits of pomegranate juice in type 2 diabetes and its complications.

Lipid Profile Improvements with Pomegranate Juice

Effects on Cholesterol Levels

Several studies have investigated the effects of pomegranate juice on lipid profiles in individuals with type 2 diabetes:

1. LDL cholesterol: A study by Esmaillzadeh et al. (2004) found that 8 weeks of pomegranate juice consumption (40 g/day) in type 2 diabetic patients with hyperlipidemia significantly reduced total cholesterol and LDL cholesterol levels.

2. HDL cholesterol: The same study by Esmaillzadeh et al. (2004) observed a significant increase in HDL cholesterol levels after pomegranate juice consumption.

3. Triglycerides: A meta-analysis by Sahebkar et al. (2016) found that pomegranate juice consumption significantly reduced triglyceride levels in patients with type 2 diabetes.

Cardiovascular Benefits for Diabetic Patients

The lipid-lowering effects of pomegranate juice may contribute to cardiovascular benefits in diabetic patients:

1. Reduction of cardiovascular risk factors: Improved lipid profiles can help reduce the risk of cardiovascular disease, a major complication of type 2 diabetes.

2. Potential mechanisms: Aviram et al. (2000) proposed that the antioxidant properties of pomegranate juice may protect LDL cholesterol from oxidation, a key step in atherosclerosis development.

3. Long-term implications: A study by Davidson et al. (2009) found that long-term pomegranate juice consumption (up to 18 months) was associated with reduced progression of carotid intima-media thickness in patients at moderate risk for coronary heart disease.

Comparison with Other Dietary Interventions

When compared to other dietary interventions for lipid management in diabetes:

1. Pomegranate juice vs. other fruit juices: A study by Basu et al. (2013) found that pomegranate juice was more effective than cranberry juice in improving lipid profiles in patients with metabolic syndrome.

2. Synergistic effects: Some research suggests that combining pomegranate juice with other dietary components may enhance its lipid-lowering effects. For example, a study by Mirmiran et al. (2010) found that pomegranate juice combined with a heart-healthy diet had greater effects on lipid profiles than either intervention alone.

3. Integration into a heart-healthy diet: The American Diabetes Association recommends a heart-healthy dietary pattern for diabetes management, which could potentially include moderate consumption of pomegranate juice as part of a balanced approach (American Diabetes Association, 2019).

While these findings are promising, it's important to note that pomegranate juice should not be considered a replacement for standard lipid-lowering therapies in diabetes management. Rather, it may serve as a complementary dietary approach when consumed in moderation.

Gut Microbiota Modulation by Pomegranate Juice

Role of Gut Microbiota in Diabetes

The gut microbiota plays a crucial role in glucose metabolism and has been implicated in the development and progression of type 2 diabetes. Dysbiosis, or an imbalance in gut microbiota composition, has been associated with insulin resistance and impaired glucose tolerance (Tilg & Moschen, 2014).

Prebiotic Effects of Pomegranate Compounds

Pomegranate juice and its compounds have shown potential prebiotic effects:

1. Impact on beneficial gut bacteria: A study by Li et al. (2015) found that pomegranate extract increased the abundance of Akkermansia muciniphila, a beneficial gut bacterium associated with improved metabolic health, in mice fed a high-fat diet.

2. Production of urolithin A: Ellagitannins in pomegranate are metabolised by gut bacteria to produce urolithin A, which has shown anti-inflammatory and antioxidant properties (Espín et al., 2013).

3. Potential mechanisms for improved glucose control: The prebiotic effects of pomegranate may contribute to improved glucose control through various mechanisms, including enhanced production of short-chain fatty acids and modulation of gut hormone secretion (Anhê et al., 2015).

Implications for Diabetes Management

The gut microbiota modulation by pomegranate juice may have several implications for diabetes management:

1. Gut-brain axis and glucose regulation: The gut microbiota communicates with the brain via the gut-brain axis, influencing appetite and glucose homeostasis. Modulation of the gut microbiota by pomegranate compounds may potentially impact these processes (Cryan et al., 2019).

2. Potential for personalised nutrition approaches: Given the individual variability in gut microbiota composition, the effects of pomegranate juice on gut health and glucose metabolism may vary between individuals. This suggests the potential for personalised nutrition approaches in diabetes management (Zeevi et al., 2015).

3. Future research directions: More research is needed to fully understand the interactions between pomegranate compounds, gut microbiota, and glucose metabolism in humans with type 2 diabetes. Long-term studies investigating the effects of pomegranate juice consumption on gut microbiota composition and metabolic outcomes in diabetic patients would be particularly valuable.

Practical Considerations for Pomegranate Juice Consumption

Recommended Intake and Serving Sizes

While there is no universally agreed-upon recommendation for pomegranate juice intake in diabetes management, most studies have used moderate amounts:

1. Guidelines for moderate consumption: A common recommendation is to consume about 1 cup (250 mL) of pomegranate juice or 1 cup of pomegranate arils per day (Basu & Penugonda, 2009).

2. Considerations for calorie and sugar content: A 250 mL serving of pomegranate juice contains approximately 134 calories and 31 grams of sugar (USDA

Conclusion

Pomegranate juice has emerged as a promising dietary component for individuals with type 2 diabetes, offering potential benefits through multiple mechanisms. The rich polyphenol content and potent antioxidant capacity of pomegranate juice may help combat oxidative stress and inflammation, two key factors in the pathogenesis of diabetes and its complications (Fenercioglu et al., 2010; Sohrab et al., 2014). Additionally, some studies have suggested positive effects on insulin sensitivity, lipid profiles, and glycemic control, although results have been mixed (Banihani et al., 2014; Esmaillzadeh et al., 2004; Sahebkar et al., 2017).

The low glycemic index of pomegranate juice, coupled with its potential to modulate digestive enzymes and carbohydrate metabolism, indicates that it may be a suitable beverage choice for individuals with diabetes when consumed in moderation (Foster-Powell et al., 2002; Li et al., 2005). Furthermore, emerging research on the prebiotic effects of pomegranate compounds and their influence on gut microbiota opens up new avenues for understanding how this fruit may impact glucose homeostasis (Li et al., 2015).

However, it is crucial to approach these findings with caution. While many studies show promise, the overall body of evidence is still developing, and more robust, long-term clinical trials are needed to fully establish the efficacy of pomegranate juice in diabetes management. Individual responses to pomegranate juice may vary, and it should not be considered a replacement for standard diabetes care or medication.

For those considering incorporating pomegranate juice into their diet, it is advisable to do so under the guidance of a healthcare professional. Monitoring blood glucose responses and being mindful of portion sizes is important, given the moderate sugar content of the juice. Whole pomegranate fruit may be preferable for some individuals due to its higher fibre content and lower glycemic impact.

In conclusion, while pomegranate juice shows potential as a complementary approach in type 2 diabetes management, it should be viewed as part of a comprehensive, balanced diet and lifestyle approach. As research continues to evolve, we may gain a clearer understanding of how to optimally harness the benefits of this ancient fruit in the context of modern diabetes care.

Key Highlights and Actionable Tips

• Pomegranate juice has a low glycemic index (35) and moderate glycemic load (18), making it a potentially suitable beverage choice for those with type 2 diabetes when consumed in moderation.
• The rich polyphenol content and antioxidant capacity of pomegranate juice may help combat oxidative stress and inflammation associated with diabetes.
• Some studies suggest pomegranate juice may improve insulin sensitivity and lipid profiles in individuals with type 2 diabetes.
• Pomegranate compounds may have prebiotic effects, potentially benefiting gut health and glucose metabolism.
• A common recommendation is to consume about 1 cup (250 mL) of pomegranate juice or 1 cup of pomegranate arils per day.
• Monitor blood glucose responses when incorporating pomegranate juice into your diet and be mindful of portion sizes due to its sugar content.
• Consider consuming whole pomegranate fruit instead of juice for higher fibre content and lower glycemic impact.
• Consult with a healthcare professional before making significant dietary changes, especially if you have diabetes.

How does pomegranate juice compare to other fruit juices in terms of glycemic impact?

Pomegranate juice has a relatively low glycemic index (GI) of 35 compared to some other fruit juices. For instance, orange juice has a higher GI of 50, while apple juice has a GI of 41. This lower GI suggests that pomegranate juice may cause a slower and more gradual rise in blood glucose levels compared to these other juices. However, it's important to note that the glycemic load (GL) of pomegranate juice is moderate at 18, indicating that portion control is still crucial for individuals with diabetes.

Can pomegranate juice interact with diabetes medications?

While the article doesn't specifically address interactions between pomegranate juice and diabetes medications, it's an important consideration. Some studies have suggested that pomegranate juice may affect the activity of certain enzymes involved in drug metabolism, potentially altering the effectiveness of some medications. For example, pomegranate juice has been shown to inhibit CYP3A4, an enzyme involved in the metabolism of many drugs (Hidaka et al., 2005). Therefore, it's crucial to consult with a healthcare provider before adding pomegranate juice to your diet if you're taking diabetes medications or any other prescription drugs.

Are there any potential side effects of consuming pomegranate juice for people with diabetes?

The article doesn't explicitly mention side effects, but there are some potential concerns to be aware of. While pomegranate juice is generally considered safe for most people, its sugar content could potentially affect blood glucose levels if consumed in large quantities. Some individuals may also experience digestive issues like diarrhoea or stomach upset when consuming too much pomegranate juice. Additionally, pomegranate juice may interact with certain medications, as mentioned earlier. It's always best to start with small amounts and monitor your body's response, and to discuss any new dietary additions with your healthcare provider.

How does the nutritional profile of whole pomegranate fruit differ from pomegranate juice?

While the article focuses primarily on pomegranate juice, it's worth noting the differences between the juice and whole fruit. Whole pomegranate fruit contains the edible seeds (arils) which are rich in fibre, a nutrient largely absent in the juice. This fibre content can help slow down sugar absorption and provide additional health benefits. Whole pomegranates also contain less sugar per serving compared to the concentrated juice. For example, a 100g serving of pomegranate arils contains about 14g of sugar, while the same amount of juice contains around 13g but lacks the fibre (USDA, 2019). The whole fruit may therefore have a lower glycemic impact and could be a preferable option for some individuals with diabetes.

What is the best time of day to consume pomegranate juice for potential glycemic benefits?

The article doesn't specify an optimal time for consuming pomegranate juice. However, based on general principles of blood glucose management, there might be potential benefits to strategic timing. Some studies have shown that consuming certain polyphenol-rich foods before a meal can help reduce postprandial glucose spikes (Coe & Ryan, 2016). Therefore, drinking a small amount of pomegranate juice before a meal might potentially help moderate the glycemic response to that meal. However, this is a general principle and may not apply equally to everyone. As always, it's best to monitor your own blood glucose responses and consult with a healthcare provider for personalised advice.

References

American Diabetes Association. (2019). 5. Lifestyle Management: Standards of Medical Care in Diabetes—2019. Diabetes Care, 42(Supplement 1), S46-S60. https://doi.org/10.2337/dc19-S005

Anhê, F. F., Roy, D., Pilon, G., Dudonné, S., Matamoros, S., Varin, T. V., ... & Marette, A. (2015). A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut, 64(6), 872-883. https://doi.org/10.1136/gutjnl-2014-307142

Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., ... & Fuhrman, B. (2000). Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E–deficient mice. The American Journal of Clinical Nutrition, 71(5), 1062-1076. https://doi.org/10.1093/ajcn/71.5.1062

Aviram, M., Rosenblat, M., Gaitini, D., Nitecki, S., Hoffman, A., Dornfeld, L., ... & Hayek, T. (2004). Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clinical Nutrition, 23(3), 423-433. https://doi.org/10.1016/j.clnu.2003.10.002

Bagri, P., Ali, M., Aeri, V., Bhowmik, M., & Sultana, S. (2009). Antidiabetic effect of Punica granatum flowers: Effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Food and Chemical Toxicology, 47(1), 50-54. https://doi.org/10.1016/j.fct.2008.09.058

Banihani, S., Swedan, S., & Alguraan, Z. (2013). Pomegranate and type 2 diabetes. Nutrition Research, 33(5), 341-348. https://doi.org/10.1016/j.nutres.2013.03.003

Banihani, S. A., Makahleh, S. M., El-Akawi, Z., Al-Fashtaki, R. A., Khabour, O. F., Gharibeh, M. Y., ... & Alkofahi, A. S. (2014). Fresh pomegranate juice ameliorates insulin resistance, enhances β-cell function, and decreases fasting serum glucose in type 2 diabetic patients. Nutrition Research, 34(10), 862-867. https://doi.org/10.1016/j.nutres.2014.08.003

Basu, A., & Penugonda, K. (2009). Pomegranate juice: a heart-healthy fruit juice. Nutrition Reviews, 67(1), 49-56. https://doi.org/10.1111/j.1753-4887.2008.00133.x

Basu, A., Betts, N. M., Ortiz, J., Simmons, B., Wu, M., & Lyons, T. J. (2013). Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome. Nutrition Research, 33(1), 41-48. https://doi.org/10.1016/j.nutres.2012.11.005

Cryan, J. F., O'Riordan, K. J., Cowan, C. S., Sandhu, K. V., Bastiaanssen, T. F., Boehme, M., ... & Dinan, T. G. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877-2013. https://doi.org/10.1152/physrev.00018.2018

Davidson, M. H., Maki, K. C., Dicklin, M. R., Feinstein, S. B., Witchger, M., Bell, M., ... & Aviram, M. (2009). Effects of consumption of pomegranate juice on carotid intima–media thickness in men and women at moderate risk for coronary heart disease. The American Journal of Cardiology, 104(7), 936-942. https://doi.org/10.1016/j.amjcard.2009.05.037

Esmaillzadeh, A., Tahbaz, F., Gaieni, I., Alavi-Majd, H., & Azadbakht, L. (2004). Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. Journal of Medicinal Food, 7(3), 305-308. https://doi.org/10.1089/jmf.2004.7.305

Espín, J. C., Larrosa, M., García-Conesa, M. T., & Tomás-Barberán, F. (2013). Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evidence-Based Complementary and Alternative Medicine, 2013. https://doi.org/10.1155/2013/270418

Fenercioglu, A. K., Saler, T., Genc, E., Sabuncu, H., & Altuntas, Y. (2010). The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in Type 2 diabetes mellitus without complications. Journal of Endocrinological Investigation, 33(2), 118-124. https://doi.org/10.1007/BF03346565

Foster-Powell, K., Holt, S. H., & Brand-Miller, J. C. (2002). International table of glycemic index and glycemic load values: 2002. The American Journal of Clinical Nutrition, 76(1), 5-56. https://doi.org/10.1093/ajcn/76.1.5

Gil, M. I., Tomás-Barberán, F. A., Hess-Pierce, B., Holcroft, D. M., & Kader, A. A. (2000). Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. Journal of Agricultural and Food Chemistry, 48(10), 4581-4589. https://doi.org/10.1021/jf000404a

Hontecillas, R., O'Shea, M., Einerhand, A., Diguardo, M., & Bassaganya-Riera, J. (2009). Activation of PPAR γ and α by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation. Journal of the American College of Nutrition, 28(2), 184-195. https://doi.org/10.1080/07315724.2009.10719770

Kerimi, A., Nyambe-Silavwe, H., Gauer, J. S., Tomás-Barberán, F. A., & Williamson, G. (2017). Pomegranate juice, but not an extract, confers a lower glycemic response on a high–glycemic index food: randomized, crossover, controlled trials in healthy subjects. The American Journal of Clinical Nutrition, 106(6), 1384-1393. https://doi.org/10.3945/ajcn.117.161968

Khoo, N. K., White, C. R., Pozzo-Miller, L., Zhou, F., Constance, C., Inoue, T., ... & Schopfer, F. J. (2011). Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radical Biology and Medicine, 50(6), 669-679. https://doi.org/10.1016/j.freeradbiomed.2010.12.030

Lee, C. J., Chen, L. G., Liang, W. L., & Wang, C. C. (2010). Anti-inflammatory effects of Punica granatum Linne in vitro and in vivo. Food Chemistry, 118(2), 315-322. https://doi.org/10.1016/j.foodchem.2009.04.123

Li, Y., Guo, C., Yang, J., Wei, J., Xu, J., & Cheng, S. (2006). Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food Chemistry, 96(2), 254-260. https://doi.org/10.1016/j.foodchem.2005.02.033

Li, Z., Henning, S. M., Lee, R. P., Lu, Q. Y., Summanen, P. H., Thames, G., ... & Heber, D. (2015). Pomegranate extract induces ellagitannin metabolite formation and changes stool microbiota in healthy volunteers. Food & Function, 6(8), 2487-2495. https://doi.org/10.1039/C5FO00669D

Makino-Wakagi, Y., Yoshimura, Y., Uzawa, Y., Zaima, N., Moriyama, T., & Kawamura, Y. (2012). Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes. Biochemical and Biophysical Research Communications, 417(2), 880-885. https://doi.org/10.1016/j.bbrc.2011.12.067

Mirmiran, P., Fazeli, M. R., Asghari, G., Shafiee, A., & Azizi, F. (2010). Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial. British Journal of Nutrition, 104(3), 402-406. https://doi.org/10.1017/S0007114510000504

Rasheed, Z., Akhtar, N., Anbazhagan, A. N., Ramamurthy, S., Shukla, M., & Haqqi, T. M. (2009). Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-κB in human KU812 cells. Journal of Inflammation, 6(1), 1-12. https://doi.org/10.1186/1476-9255-6-1

Rozenberg, O., Howell, A., & Aviram, M. (2006). Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it. Atherosclerosis, 188(1), 68-76. https://doi.org/10.1016/j.atherosclerosis.2005.10.027

Sahebkar, A., Ferri, C., Giorgini, P., Bo, S., Nachtigal, P., & Grassi, D. (2017). Effects of pomegranate juice on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research, 115, 149-161. https://doi.org/10.1016/j.phrs.2016.11.018

Sahebkar, A., Simental-Mendía, L. E., Giorgini, P., Ferri, C., & Grassi, D. (2016). Lipid profile changes after pomegranate consumption: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine, 23(11), 1103-1112. https://doi.org/10.1016/j.phymed.2015.12.014

Sohrab, G., Nasrollahzadeh, J., Zand, H., Amiri, Z., Tohidi, M., & Kimiagar, M. (2014). Effects of pomegranate juice consumption on inflammatory markers in patients with type 2 diabetes: A randomized, placebo-controlled trial. Journal of Research in Medical Sciences, 19(3), 215-220.

Tilg, H., & Moschen, A. R. (2014). Microbiota and diabetes: an evolving relationship. Gut, 63(9), 1513-1521. http://dx.doi.org/10.1136/gutjnl-2014-306928

Tugcu, V., Kemahli, E., Ozbek, E., Arinci, Y. V., Uhri, M., Erturkuner, P., ... & Tasci, A. I. (2008). Protective effect of a potent antioxidant, pomegranate juice, in the kidney of rats with nephrolithiasis induced by ethylene glycol. Journal of Endourology, 22(12), 2723-2732. https://doi.org/10.1089/end.2008.0357

Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., ... & Segal, E. (2015). Personalized nutrition by prediction of glycemic responses. Cell, 163(5), 1079-1094. https://doi.org/10.1016/j.cell.2015.11.001